News
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone," but experts say concerns ...
6d
The Texas Tribune on MSNTexas capital murder case attempts to severely punish abortion pill use by treating a fetus as a personA North Texas man charged with capital murder after slipping mifepristone into his girlfriend’s food signals another attempt ...
An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...
13d
MedPage Today on MSNMifepristone Helped Control Diabetes in Those With Hypercortisolism"This is potentially paradigm-shifting data," Buse previously told MedPage Today, adding that the investigators were "shocked ...
3d
The Moscow Times on MSNEmergency Contraceptives Disappear from Russian Pharmacies – VyorstkaEmergency contraceptives and medical abortion drugs have all but disappeared from Russian pharmacy shelves after authorities ...
Experts: Mifepristone is 'safer than Tylenol,' Viagra. Mifepristone is among "the most studied medications" prescribed in the United States, according to an amicus brief filed in support of the ...
Mifepristone can continue to be mailed to patients without an in-person visit with a doctor after the US Supreme Court rejected a lawsuit that challenged regulation of the abortion pill ...
They were randomised in a 2:1 ratio to receive either mifepristone (300–900 mg daily) or placebo for 24 weeks. Randomisation ...
Mifepristone's approval has been questioned before. This isn't the first time there have been allegations that the FDA bungled the approval of mifepristone, which was known as RU-486 early on.
11don MSNOpinion
FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.
Researchers have discovered in a randomized placebo-controlled trial that mifepristone (Korlym) led to a significant ...
The move follows an announcement by Secretary Robert F. Kennedy Jr. that the FDA will be conducting a review of mifepristone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results